Manuel A. Pascual

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


411 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ...
Sous presse
 
Surgical site infections after kidney transplantation are independently associated with graft loss.
Schreiber P.W., Hoessly L.D., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al. American journal of transplantation. Peer-reviewed.
[DOI][Pmid][serval:BIB_5E28895E3E42]
2024
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA450EA2BB8A]
Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial).
Mombelli M., Neofytos D., Huynh-Do U., Sánchez-Céspedes J., Stampf S., Golshayan D., Dahdal S., Stirnimann G., Schnyder A., Garzoni C. et al., 2024/01/25. Clinical infectious diseases, 78 (1) pp. 48-56. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F905F25D58E1]
 
Face au désenchantement des étudiants en médecine, les facultés sont prêtes à innover.
Geissbühler A., Pascual M., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 5-8. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9DDE7D621604]
2023
Post-transplant survival with pre-transplant durable continuous-flow mechanical circulatory support in a Swiss cohort of heart transplant recipients.
Hullin R., Abdurashidova T., Pitta-Gros B., Schukraft S., Rancati V., Lu H., Zurbuchen A., Marcucci C., Ltaief Z., Lefol K. et al., 2023/12/04. Swiss medical weekly, 153 p. 3500. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BA5B1E63C249]
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/11. Open forum infectious diseases, 10 (11) pp. ofad536. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA0E2350DF22]
Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.
Neofytos D., Stampf S., Hoessly L.D., D'Asaro M., Tang G.N., Boggian K., Hirzel C., Khanna N., Manuel O., Mueller N.J. et al., 2023/06. Open forum infectious diseases, 10 (6) pp. ofad247. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_93C3850C4E55]
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
Walti L.N., Mugglin C., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N.J., Berger C., Boggian K., Garzoni C. et al., 2023/04/03. JAMA network open, 6 (4) pp. e2310687. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F026B83CBA0]
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/04. Open forum infectious diseases, 10 (4) pp. ofad150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EA3FA50DC390]
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol.
Schwab S., Sidler D., Haidar F., Kuhn C., Schaub S., Koller M., Mellac K., Stürzinger U., Tischhauser B., Binet I. et al., 2023/03/07. Diagnostic and prognostic research, 7 (1) p. 6. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_69CC7CCAA980]
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
de Rougemont O., Deng Y., Frischknecht L., Wehmeier C., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2023. Frontiers in immunology, 14 p. 1104371. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9C3FDBD902B3]
2022
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients.
Pham T.T., Andrey D.O., Stampf S., Burkhard S.H., Hirzel C., Tschopp J., Ullrich K., Strahm C., Schreiber P.W., Boillat-Blanco N. et al., 2022/12. American journal of transplantation, 22 (12) pp. 3031-3046. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FE1913230C55]
 
Regression of Graft Steatosis After Liver Transplantation.
Meyer H., Maurer M.H., Staufer K., Berzigotti A., Banz V., Swiss Transplant Cohort Study, 2022/12. Progress in transplantation, 32 (4) pp. 321-326. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8EDCB6B832F1]
Robotic versus hand-assisted laparoscopic living donor nephrectomy: comparison of two minimally invasive techniques in kidney transplantation.
Windisch O.L., Matter M., Pascual M., Sun P., Benamran D., Bühler L., Iselin C.E., 2022/12. Journal of robotic surgery, 16 (6) pp. 1471-1481. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F673B943242C]
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Laager M., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2022/10. The Journal of hospital infection, 128 pp. 47-53. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CFE763A8A63]
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study.
Becchetti C., Dirchwolf M., Schropp J., Magini G., Müllhaupt B., Immer F., Dufour J.F., Banz V., Berzigotti A., Bosch J. et al., 2022/10. Alimentary pharmacology & therapeutics, 56 (7) pp. 1194-1204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9E54BA86BE04]
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
Speich B., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2022/08/24. Clinical infectious diseases, 75 (1) pp. e585-e593. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B952B5300090]
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
Kusejko K., Chammartin F., Smith D., Odermatt M., Schuhmacher J., Koller M., Günthard H.F., Briel M., Bucher H.C., Speich B. et al., 2022/07/28. BMC infectious diseases, 22 (1) p. 654. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_66CD4B7631A4]
 
The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality.
Dirchwolf M., Becchetti C., Gschwend S.G., Toso C., Dutkowski P., Immer F., Beyeler F., Rossi S., Schropp J., Dufour J.F. et al., 2022/07. HPB, 24 (7) pp. 1168-1176. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_63DBC81F8439]
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid M., Suffiotti M., Pellaton C., Bouchaab H., Cairoli A., Salvadé V., Stevenel C., Hottinger R., Pythoud C., Coutechier L. et al., 2022/05/01. JAMA oncology, 8 (5) pp. e220446. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8956034C5615]
Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.
Kasmi S., Artru F., Barbosa J.V., Deibel A.R., Favre L., Peuble C., Saouli A.C., Goossens N., Müllhaupt B., Pascual M. et al., 2022/02/28. Swiss medical weekly, 152 pp. w30138. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_14011818DC4B]
Has the profile of heart transplantation recipients changed within the last three decades?
Anouck Z., Tozzi P., Regamey J., Abdurashidova T., Meyer P., Lefol K., Pascual M., Yerly P., Aubert V., Aur S. et al., 2022/01/17. Swiss medical weekly, 152 pp. w30108. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31EADDEE19EC]
A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study.
Beckmann S., Mauthner O., Schick L., Rochat J., Lovis C., Boehler A., Binet I., Huynh-Do U., De Geest S., Psychosocial Interest Group et al., 2022. Transplant international, 35 p. 10255. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8FB33FC7EE7F]
Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation.
Porret R., Meier RPH, Mikulic J., Pascual M., Aubert V., Harr T., Golshayan D., Muller Y.D., 2022. Frontiers in immunology, 13 p. 997364. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3741B3D0D5D4]
Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.
Yerly P., Rotman S., Regamey J., Aubert V., Aur S., Kirsch M., Hullin R., Pascual M., 2022/01. Xenotransplantation, 29 (1) pp. e12726. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_81DB4AE7643B]
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients.
van den Bogaart L., Lang B.M., Neofytos D., Egli A., Walti L.N., Boggian K., Garzoni C., Berger C., Pascual M., van Delden C. et al., 2022/01. American journal of transplantation, 22 (1) pp. 199-209. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1437EFD0493F]
 
Xenotransplantation: A New Era.
Carrier A.N., Verma A., Mohiuddin M., Pascual M., Muller Y.D., Longchamp A., Bhati C., Buhler L.H., Maluf D.G., Meier RPH, 2022. Frontiers in immunology, 13 p. 900594. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_967E8862A91F]
2021
Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland.
Stampf S., Mueller N.J., van Delden C., Pascual M., Manuel O., Banz V., Binet I., De Geest S., Bochud P.Y., Leichtle A. et al., 2021/12/15. BMJ open, 11 (12) pp. e051176. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_83070D337875]
 
Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study.
Wehmeier C., Amico P., Sidler D., Wirthmüller U., Hadaya K., Ferrari-Lacraz S., Golshayan D., Aubert V., Schnyder A., Sunic K. et al., 2021/12. Transplant international, 34 (12) pp. 2755-2768. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD21EC0FD8B7]
 
COVID-19 as a potential trigger of complement-mediated atypical HUS.
El Sissy C., Saldman A., Zanetta G., Martins P.V., Poulain C., Cauchois R., Kaplanski G., Venetz J.P., Bobot M., Dobosziewicz H. et al., 2021/11/04. Blood, 138 (18) pp. 1777-1782. Peer-reviewed.
[DOI][Pmid][serval:BIB_6916C0B7F2B4]
 
Use of induction therapy in pediatric heart transplant recipients in Switzerland - Analysis of the Swiss national database.
Schweiger M., Erdil T., Di Bernardo S., Balmer C., Yildiz M., Kadner A., Swiss Transplant Cohort Study, 2021/10. Transplant immunology, 68 p. 101443. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3678433800F]
Tribute to Professor Stefan Kunz.
Pascual M., 2021/09/18. Viruses, 13 (9) p. 1862. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C69C3C0DDAB]
 
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial.
Mombelli M., Hoschler K., Cavassini M., Pascual M., Manuel O., 2021/09. The Journal of infection, 83 (3) pp. 354-360. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8399DF169607]
Demographic, psychosocial and health disparities between living and deceased renal allograft recipients in Switzerland.
Achermann R., Koller M., De Geest S., Hadaya K., Müller T.F., Huynh-Do U., Pascual M., Steiger J., Kiss A., Binet I. et al., 2021/08/02. Swiss medical weekly, 151 pp. w20532. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A17EC6EF7AE]
Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports.
Chehade H., Guzzo G., Cachat F., Rotman S., Teta D., Pantaleo G., Sadallah S., Sharma A., Rosales I.A., Tolkoff-Rubin N. et al., 2021/07/31. Frontiers in medicine, 8 p. 663258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_78558A2B0C1B]
Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
Guzzo G., Kissling S., Pantaleo G., Pascual M., Sadallah S., Teta D., 2021/07/06. BMC nephrology, 22 (1) p. 252. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5BD58C2F1EDF]
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study.
Mombelli M., Lang B.M., Neofytos D., Aubert J.D., Benden C., Berger C., Boggian K., Egli A., Soccal P.M., Kaiser L. et al., 2021/05. American journal of transplantation, 21 (5) pp. 1789-1800. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62F7E74F1E7D]
 
Recent progress and remaining hurdles toward clinical xenotransplantation.
Meier RPH, Longchamp A., Mohiuddin M., Manuel O., Vrakas G., Maluf D.G., Buhler L.H., Muller Y.D., Pascual M., 2021/05. Xenotransplantation, 28 (3) pp. e12681. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3232FC94FF85]
 
Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation: The Swiss Transplant Cohort study.
Denhaerynck K., Goldfarb-Rumyantzev A.S., Sandhu G., Beckmann S., Huynh-Do U., Binet I., De Geest S., Psychosocial Interest Group, Swiss Transplant Cohort Study, 2021/04. Clinical transplantation, 35 (4) pp. e14218. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A1F00A6FCAA4]
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
Kohler P., Wolfensberger A., Stampf S., Brönnimann A., Boggian K., van Delden C., Favre M., Hirzel C., Khanna N., Kuster S.P. et al., 2021/03/07. Antimicrobial resistance and infection control, 10 (1) p. 50. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_23A5D4CD5C8E]
Complément et rein [Complement system and kidney]
Halfon M., Pascual M., Sadallah S., Fakhouri F., 2021/02/24. Revue medicale suisse, 17 (727) pp. 383-388. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_83627E067A3D]
Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials.
Lizaraso-Soto F., Gutiérrez-Abejón E., Bustamante-Munguira J., Martín-García D., Chimeno M.M., Nava-Rebollo Á., Maurtua-Briseño-Meiggs Á., Fernández-Zoppino D., Bustamante-Munguira E., de Paz F.J. et al., 2021. Frontiers in medicine, 8 p. 686729. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E234990D128]
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
Guzzo G., Sadallah S., Fodstad H., Venetz J.P., Rotman S., Teta D., Gauthier T., Pantaleo G., Superti-Furga A., Pascual M., 2021. Frontiers in genetics, 12 p. 529236. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA15A6D9CD84]
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
Perrottet N., Fernández-Ruiz M., Binet I., Dickenmann M., Dahdal S., Hadaya K., Müller T., Schaub S., Koller M., Rotman S. et al., 2021. PloS one, 16 (4) pp. e0250829. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8D676A182CA8]
2020
Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
Krisl A., Stampf S., Hauri D., Binet I., Mueller T., Sidler D., Hadaya K., Golshayan D., Pascual M., Koller M. et al., 2020/11/30. Swiss medical weekly, 150 pp. w20354. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2B3CCE87CDD3]
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study.
van Delden C., Stampf S., Hirsch H.H., Manuel O., Meylan P., Cusini A., Hirzel C., Khanna N., Weisser M., Garzoni C. et al., 2020/10/23. Clinical infectious diseases, 71 (7) pp. e159-e169. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4807130977C]
COVID-19 in an international European liver transplant recipient cohort.
Becchetti C., Zambelli M.F., Pasulo L., Donato M.F., Invernizzi F., Detry O., Dahlqvist G., Ciccarelli O., Morelli M.C., Fraga M. et al., 2020/10. Gut, 69 (10) pp. 1832-1840. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AD0AF3B9E949]
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Tschopp J., L'Huillier A.G., Mombelli M., Mueller N.J., Khanna N., Garzoni C., Meloni D., Papadimitriou-Olivgeris M., Neofytos D., Hirsch H.H. et al., 2020/10. American journal of transplantation, 20 (10) pp. 2876-2882. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62886B377225]
The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies.
Bernuy-Guevara C., Chehade H., Muller Y.D., Vionnet J., Cachat F., Guzzo G., Ochoa-Sangrador C., Álvarez F.J., Teta D., Martín-García D. et al., 2020/09/16. Biomedicines, 8 (9) pp. E355. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A5D098516B01]
 
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study.
Vu D.L., Dayer J.A., Masouridi-Levrat S., Combescure C., Boely E., Khanna N., Mueller N.J., Kleber M., Medinger M., Halter J. et al., 2020/08. Transplant infectious disease, 22 (4) pp. e13289. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C8EB192EA5DF]
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Schwotzer N., Paganetti G., Barchi M., Perrottet N., Aubert V., Sadallah S., Rotman S., Venetz J.P., Matter M., Golshayan D. et al., 2020/07. Xenotransplantation, 27 (4) pp. e12630. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_119F4B750A1D]
Impact of kidney transplantation on sleep apnea severity: A prospective polysomnographic study.
Forni Ogna V., Ogna A., Haba-Rubio J., Nowak G., Venetz J.P., Golshayan D., Matter M., Burnier M., Pascual M., Heinzer R., 2020/06. American journal of transplantation, 20 (6) pp. 1659-1667. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7133F793E2E3]
Real-life food-safety behavior and incidence of foodborne infections in solid organ transplant recipients.
Lindup M., van den Bogaart L., Golshayan D., Aubert J.D., Vionnet J., Regamey J., Pascual M., Manuel O., Mombelli M., 2020/05. American journal of transplantation, 20 (5) pp. 1424-1430. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D8A5B5FDB9AB]
Infection à SARS-CoV-2 et transplantation d’organes solides [SARS-CoV-2 infection and solid organ transplantation]
Golshayan D., Aubert J.D., Hullin R., Moradpour D., Venetz J.P., Manuel O., Pascual M., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 815-818. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A2E2665FD9D7]
Management of allergy transfer upon solid organ transplantation.
Muller Y.D., Vionnet J., Beyeler F., Eigenmann P., Caubet J.C., Villard J., Berney T., Scherer K., Spertini F., Fricker M.P. et al., 2020/03. American journal of transplantation, 20 (3) pp. 834-843. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B4CCBADEDA6A]
Donor-specific antibodies in liver transplantation.
Vionnet J., Sempoux C., Pascual M., Sánchez-Fueyo A., Colmenero J., 2020/01. Gastroenterologia y hepatologia, 43 (1) pp. 34-45. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6B0092FDA46]
2019
Impact of an intra-abdominal cooling device during open kidney transplantation in pigs.
Longchamp A., Meier RPH, Colucci N., Balaphas A., Orci L.A., Nastasi A., Longchamp G., Moll S., Klauser A., Pascual M. et al., 2019/12/16. Swiss medical weekly, 149 pp. w20143. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CDAD0E3A442A]
Nonvascularized human skin chronic allograft rejection.
Rotman S., Koch N., Wiesner L., Aubert V., Rosales I.A., Colvin R.B., Raffoul W., Pascual M., 2019/11. American journal of transplantation, 19 (11) pp. 3191-3196. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_99FA1291AC19]
 
Burden of end-stage renal disease and evolving challenges in kidney transplantation.
Golshayan D., Pascual M., 2019/09. Transplant international, 32 (9) pp. 889-891. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F5308E6FDAEB]
 
Suivi ambulatoire du patient transplanté hépatique: le rôle essentiel du médecin généraliste [Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner]
Henchoz S., Fraga M., Saouli A.C., Elkrief L., Berney T., Toso C., Compagnon P., Andres A., Denys A., Pascual M. et al., 2019/08/28. Revue medicale suisse, 15 (660) pp. 1488-1495. Peer-reviewed.
[Pmid][serval:BIB_39320710DEE8]
 
Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
Kaminski H., Jarque M., Halfon M., Taton B., Di Ascia L., Pfirmann P., Visentin J., Garrigue I., Déchanet-Merville J., Moreau J.F. et al., 2019/07/31. The Journal of infectious diseases, 220 (5) pp. 761-771. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3FA288C9277D]
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
Fraga M., Gouttenoire J., Sahli R., Chtioui H., Marcu C., Pascual M., Moradpour D., Vionnet J., 2019/05/24. BMC gastroenterology, 19 (1) p. 76. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10FD0B1931C2]
 
Evaluation of donor kidneys prior to transplantation: an update of current and emerging methods.
Moeckli B., Sun P., Lazeyras F., Morel P., Moll S., Pascual M., Bühler L.H., 2019/05. Transplant international, 32 (5) pp. 459-469. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F04DBBDF5E3B]
Impact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: A systematic review and meta-analysis.
Fernández-Ruiz M., Giménez E., Lora D., Aguado J.M., Pascual M., Manuel O., 2019/04. American journal of transplantation, 19 (4) pp. 1072-1085. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DCCBD6B537B5]
 
Variations et anomalies néphrologiques, vasculaires et urologiques chez les candidats au don vivant rénal [Renal, vascular and urological variations and abnormalities in living kidney donor candidates]
Costa A., Matter M., Pascual M., Doerfler A., Venetz J.P., 2019/03. Progres en urologie, 29 (3) pp. 166-172. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F326C6AD690]
 
Genetic and clinic predictors of new onset diabetes mellitus after transplantation.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Mueller N.J., Binet I., Van Delden C., Steiger J., Mohacsi P. et al., 2019/02. The pharmacogenomics journal, 19 (1) pp. 53-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA7F0AAB7E2E]
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J. et al., 2019/01. American journal of transplantation, 19 (1) pp. 238-246. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6D920C4CDD77]
 
Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Bischoff-Ferrari H.A., Boggian K., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H., Hirzel C., Manuel O. et al., 2019/01. Transplant international, 32 (1) pp. 49-58. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8EEF7FDA7F91]
2018
Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. Data in brief, 21 pp. 2567-2575. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F6AAF8562C2]
 
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S., Stampf S., Gerber B., Baettig V., Weisser M., Gerull S., Medinger M., Passweg J., Schanz U., Garzoni C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12981. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14D606BDD623]
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D., Hirzel C., Boely E., Lecompte T., Khanna N., Mueller N.J., Boggian K., Cusini A., Manuel O., van Delden C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12984. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B857EB67958D]
 
The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. International immunopharmacology, 65 pp. 483-492. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87F4826FC3D2]
 
New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.
Beckmann S., Denhaerynck K., Stampf S., Saigi-Morgui N., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group, Swiss Transplant Cohort Study, 2018/11. Transplant international, 31 (11) pp. 1254-1267. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_939EA1F073F3]
 
Efficient B cell Depletion With Rituximab Despite Massive Proteinuria.
Halfon M., Pascual M., Aubert V., Rotman S., Yannick M.D., 2018/10. Transplantation, 102 (10) pp. e401-e402. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A39294230312]
 
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M., Rettby N., Perreau M., Pascual M., Pantaleo G., Manuel O., 2018/10/01. Vaccine, 36 (41) pp. 6163-6169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38C298B3CEB2]
 
Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei N., Koutsokera A., Pasquier J., Mombelli M., Meylan P., Pascual M., Aubert J.D., Manuel O., 2018/08. Transplant infectious disease, 20 (4) pp. e12893. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53680F51E25F]
 
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Neofytos D., Chatzis O., Nasioudis D., Boely Janke E., Doco Lecompte T., Garzoni C., Berger C., Cussini A., Boggian K., Khanna N. et al., 2018/08. Transplant infectious disease, 20 (4) pp. e12898. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B74350F70BA5]
Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
Cusini A., Béguelin C., Stampf S., Boggian K., Garzoni C., Koller M., Manuel O., Meylan P., Mueller N.J., Hirsch H.H. et al., 2018/07. American journal of transplantation, 18 (7) pp. 1745-1754. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10C3CE32D79C]
Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.
Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M., 2018/06. Transplantation, 102 (6) pp. e301-e303. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A55614976F55]
 
Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation.
Vionnet J., Yerly P., Aubert J.D., Pascual M., Aldenkortt F., Berney T., Giostra E., Moradpour D., Schiffer E., 2018/05. Transplantation, 102 (5) pp. e194. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE49AE33421F]
 
Xenotransplantation: back to the future?
Meier RPH, Muller Y.D., Balaphas A., Morel P., Pascual M., Seebach J.D., Buhler L.H., 2018/05. Transplant international, 31 (5) pp. 465-477. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_571A0830C12B]
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Muller Y.D., Ghaleb N., Rotman S., Vionnet J., Halfon M., Catana E., Golshayan D., Venetz J.P., Aubert V., Pascual M., 2018/04. Transplant international, 31 (4) pp. 451-455. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C54B7A2AC6FE]
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.
López-Medrano F., Fernández-Ruiz M., Silva J.T., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2018/02. Clinical microbiology and infection, 24 (2) pp. 192-198. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3DD38C51841F]
Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature.
Libudzic-Nowak A.M., Cachat F., Pascual M., Chehade H., 2018. Frontiers in pediatrics, 6 p. 398. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D162D023E8F2]
2017
 
Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.
Gero D., Dib F., Matter M., Pascual M., Venetz J.P., Demartines N., Melloul E., 2017/11. World journal of surgery, 41 (11) pp. 2940-2948. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4766DE5827D2]
 
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation [PLB069]
Muller Y, Ghaleb N., Rotman S, Catana E., Golshayan D, Venetz JP, Aubert V., Pascual M., 2017/10/31. pp. 553-554 dans Transplant International.
[WoS][serval:BIB_2FF3B3E15DDF]
BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.
Leboeuf C., Wilk S., Achermann R., Binet I., Golshayan D., Hadaya K., Hirzel C., Hoffmann M., Huynh-Do U., Koller M.T. et al., 2017/10. American journal of transplantation, 17 (10) pp. 2591-2600. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9BFE3E689546]
 
Early acute antibody-mediated rejection (AMR) after lung transplantation successfully treated with c5 blockade [PLB032]
Muller Y., Aubert JD, Vionnet J., Rotman S., Aubert V, Pascual M., 2017/09/30. pp. 543-543 dans Transplant International.
[WoS][serval:BIB_66BF25F6D0FA]
 
Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
Vionnet J., Pascual M., Testoni B., Combet C., Godat S., Vijgen S., Aubert V., Rubbia-Brandt L., Zoulim F., Moradpour D., 2017/09/16. Hepatology, 67 (2) pp. 791-793 . Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DD329BAFA656]
 
The impact of multidisciplinary care on early morbidity and mortality after heart transplantation.
Schmidhauser M., Regamey J., Pilon N., Pascual M., Rotman S., Banfi C., Prêtre R., Meyer P., Antonietti J.P., Hullin R., 2017/09/01. Interactive cardiovascular and thoracic surgery, 25 (3) pp. 384-390. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22E5650465D6]
Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C., Stampf S., Héquet D., Mueller N.J., Cusini A., van Delden C., Khanna N., Boggian K., Hirzel C., Soccal P. et al., 2017/07. American journal of transplantation, 17 (7) pp. 1813-1822. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_19E462B2BC1D]
 
Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation.
Simonetta F., Pradier A., Masouridi-Levrat S., van Delden C., Giostra E., Morard I., Mueller N., Muellhaupt B., Valli P.V., Semmo N. et al., 2017/07. Transplantation, 101 (7) pp. e219-e221. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8EEBC56CBE4D]
 
Evolution of body weight parameters up to 3 years after solid organ transplantation: The prospective Swiss Transplant Cohort Study.
Beckmann S., Nikolic N., Denhaerynck K., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group Swiss Transplant Cohort Study, 2017/03. Clinical transplantation, 31 (3). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA1AD77EB893]
 
ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study.
Mauthner O., Claes V., Walston J., Engberg S., Binet I., Dickenmann M., Golshayan D., Hadaya K., Huynh-Do U., Calciolari S. et al., 2017/03. Journal of advanced nursing, 73 (3) pp. 716-734. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AFEBDCCC8516]
Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.
Beaume M., Köhler T., Greub G., Manuel O., Aubert J.D., Baerlocher L., Farinelli L., Buckling A., van Delden C., Swiss Transplant Cohort Study, 2017/01/17. Scientific reports, 7 p. 40309. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A067B4F4ADC7]
 
A Renal Paratransplant Hernia Causing Complete Small Bowel Obstruction: A Case Report and Review of the Literature.
Zingg T., Teixeira Farinha H., Demartines N., Pascual M., Matter M., 2017. Transplantation proceedings, 49 (1) pp. 210-212. Peer-reviewed.
[DOI][Pmid][serval:BIB_2194B720995A]
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J. et al., 2017/01. The pharmacogenomics journal, 17 (1) pp. 69-75. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_342B86B6E988]
IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice.
Govender L., Wyss J.C., Kumar R., Pascual M., Golshayan D., 2017. Frontiers in immunology, 8 p. 421. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEE1D86C8E62]
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.
Obregon C., Kumar R., Pascual M.A., Vassalli G., Golshayan D., 2017. Frontiers in immunology, 8 p. 1514. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_94A03CF5154C]
2016
 
Blockade of C5 in Severe Acute Postinfectious Glomerulonephritis Associated With Anti-Factor H Autoantibody.
Chehade H., Rotman S., Frémeaux-Bacchi V., Aubert V., Sadallah S., Sifaki L., Salomon R., Pascual M., 2016/12. American journal of kidney diseases : the official journal of the National Kidney Foundation, 68 (6) pp. 944-948. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDAC08A45996]
 
Oral valganciclovir for CMV gastritis.
Saouli A.C., Salvade I., Saldarriaga J., Manuel O., Venetz J.P., Golshayan D., Sempoux C., Pascual M., 2016/09. Clinics and research in hepatology and gastroenterology, 40 (4) pp. e50-1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7E7FA851BA26]
 
Amyloïdose héréditaire à transthyrétine [Transthyretin-related hereditary amyloidosis]
Vionnet J., Pascual M., Kuntzer T., Yerly P., Moradpour D., 2016/08/31. Revue medicale suisse, 12 (528) pp. 1434-1440. Peer-reviewed.
[Pmid][serval:BIB_2C78D664859C]
 
Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
Héquet D., Pascual M., Lartey S., Pathirana R.D., Bredholt G., Hoschler K., Hullin R., Meylan P., Cox R.J., Manuel O., 2016/06/30. Vaccine, 34 (31) pp. 3576-3583. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_131AECC2C5F7]
 
Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Salvadé I., Aubert V., Venetz J.P., Golshayan D., Saouli A.C., Matter M., Rotman S., Pantaleo G., Pascual M., 2016/06. Human immunology, 77 (6) pp. 483-489. Peer-reviewed.
[DOI][Pmid][serval:BIB_04243BC5CAD3]
 
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
Golshayan D., Wójtowicz A., Bibert S., Pyndiah N., Manuel O., Binet I., Buhler L.H., Huynh-Do U., Mueller T., Steiger J. et al., 2016/04. Kidney international, 89 (4) pp. 927-938. Peer-reviewed.
[DOI][Pmid][serval:BIB_8C4D147BB18F]
 
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
Vijgen S., Wyss C., Meylan P., Bisig B., Letovanec I., Manuel O., Pascual M., de Leval L., 2016. Transplantation, 100 (1) pp. 134-140. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BE89E653468]
Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?
Michaud L., Ludwig G., Berney S., Rodrigues S., Niquille A., Santschi V., Favre A.S., Lange A.C., Michels A.A., Vrijens B. et al., 2016. Pharmacy practice, 14 (4) p. 822. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_27E6EAFEC1AB]
Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts.
Lorent M., Giral M., Pascual M., Koller M.T., Steiger J., Trébern-Launay K., Legendre C., Kreis H., Mourad G., Garrigue V. et al., 2016. Plos One, 11 (5) pp. e0155278. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C99E94E0A64]
 
The Challenge of Acute Antibody-Mediated Rejection in Kidney Transplantation.
Chehade H., Pascual M., 2016. Transplantation, 100 (2) pp. 264-265. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E9EF5796B3F8]
 
Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease.
Vionnet J., Saouli A.C., Pascual M., Stucker F., Decosterd L.A., Moradpour D., Chtioui H., 2016. Journal of Hepatology, 65 (5) pp. 1063-1065. Peer-reviewed.
[DOI][Pmid][serval:BIB_D327874A3973]
Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
Héquet D., Kralidis G., Carrel T., Cusini A., Garzoni C., Hullin R., Meylan P.R., Mohacsi P., Mueller N.J., Ruschitzka F. et al., 2016. Bmc Infectious Diseases, 16 p. 321. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F0F12B5AC40F]
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Wojtowicz A., Bibert S., Beckmann S., Mueller N.J., Binet I. et al., 2016. PloS one, 11 (10) pp. e0164443. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ADE82491851D]
2015
 
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Hirsch H. et al., 2015/08/15. Clinical infectious diseases, 61 (4) pp. 619-622. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2869E1CA81A7]
 
Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity.
Roehrich M.E., Wyss J.C., Kumar R., Pascual M., Golshayan D., Vassalli G., 2015. Immunopharmacology and Immunotoxicology, 37 (5) pp. 434-441. Peer-reviewed.
[DOI][Pmid][serval:BIB_F4E32BE7E1F8]
 
Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy.
Halfon M., Rotman S., Egli M., Venetz J.P., Pascual M., 2015. Acta Diabetologica, 52 (6) pp. 1175-1177. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_419BA407900F]
 
Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient.
Chehade H., Rotman S., Matter M., Girardin E., Aubert V., Pascual M., 2015. Pediatrics, 135 (2) pp. e551-e555. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2A471BDF7098]
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
Wójtowicz A., Gresnigt M.S., Lecompte T., Bibert S., Manuel O., Joosten L.A., Rüeger S., Berger C., Boggian K., Cusini A. et al., 2015. Journal of Infectious Diseases, 211 (10) pp. 1646-1657. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_06059AAED722]
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
Manuel O., Wójtowicz A., Bibert S., Mueller N.J., van Delden C., Hirsch H.H., Steiger J., Stern M., Egli A., Garzoni C. et al., 2015. Journal of Infectious Diseases, 211 (6) pp. 906-914.
[URN][DOI][WoS][Pmid][serval:BIB_653026F3E5A8]
 
Le rôle des associations de patients face au don d'organes en Suisse romande [Organ donation and the role of patients' associations in Western Switzerland].
Kaech F., Barras V., Pascual M., Hammer R., 2015. Revue Médicale Suisse, 11 (496) pp. 2250-2253.
[Pmid][serval:BIB_F7DEF6A5D80F]
 
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.
Schmied L., Terszowski G., Gonzalez A., Schmitter K., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C. et al., 2015. Transplantation, 99 (12) pp. 2651-2655. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53EDE710E344]
Reply to Cunha et al.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Khanna N. et al., 2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (12) pp. 1894-1895. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF730901AFF6]
Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.
Vionnet J., Pascual M., Chtioui H., Giostra E., Majno P.E., Decosterd L.A., Moradpour D., 2015. BMC Gastroenterology, 15 (1) p. 38. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2416C6CBDE27]
 
The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation.
Martin-Gandul C., Mueller N.J., Pascual M., Manuel O., 2015. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 15 (12) pp. 3024-3040.
[DOI][WoS][Pmid][serval:BIB_8710031D5CD8]
 
Time-Dependent Specificity of Immunopathologic (C4d-CD68) and Histologic Criteria of Antibody-Mediated Rejection for Donor-Specific Antibodies and Allograft Dysfunction in Heart Transplantation.
Yerly P., Rotman S., Nobile A., Aubert V., Tozzi P., Yarol N., Vogt P., Hullin R., Pascual M., 2015. Transplantation, 99 (3) pp. 586-593.
[DOI][WoS][Pmid][serval:BIB_D6262E122241]
 
Transition en transplantation rénale [Transition in kidney transplantation].
Chehade H., Parvex P., Venetz J.P., Hadaya K., Typaldou S.A., Villard E., Vogeleisen C., Pilon N., Cachat F., Pascual M., 2015. Revue Médicale Suisse, 11 (462) pp. 456, 458-456, 460. Peer-reviewed.
[Pmid][serval:BIB_C3565A540DCE]
2014
 
Does the intermed instrument predict medication adherence in transplant recipients?
Schneider Marie P., Ludwig Gundula, Rodrigues Stephanie, Niquille Anne, Santschi Valerie, Lange Anne-Catherine, Favre Anne-Sophie, Bugnon Olivier, Pascual Manuel, Michaud Laurent et al., 2014. dans 18th Annual ESPACOMP Meeting.
[serval:BIB_A83EC58C9DC9]
 
Facteurs influençant le retour au travail après transplantation chez 61 patients rénaux ou hépatiques
Praz-Christinaz Sophie-Maria, Pascual Manuel, Pilon Nathalie, Simcox Amira, Wild Pascal, Danuser Brigitta, 2014. Revue Médicale Suisse, 10 (431) pp. 1148-1152. Peer-reviewed.
[Pmid][serval:BIB_926160C14154]
 
Heart donation after circulatory determination of death: ethically acceptable?
Dalle Ave A.L., Shaw D.M., Pascual M., Benaroyo L., 2014. Nature Reviews. Cardiology, 11 (9) p. 553. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74837BD42406]
 
Hepatitis C Virus Infection and Kidney Transplantation in 2014: What's New?
Baid-Agrawal S., Pascual M., Moradpour D., Somasundaram R., Muche M., 2014. American Journal of Transplantation, 14 (10) pp. 2206-2220.
[DOI][WoS][Pmid][serval:BIB_0C2105B26256]
 
Histological and immunological aspects of chronic skin allograft rejection
Rotman S., Aubert V., Koch N., Raffoul W., Pascual M., 2014. dans 80th annual congress of the Swiss Society of Pathology.
[serval:BIB_292051285396]
 
Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F., Pascual M., Hullin R., Yerly P., Tozzi P., Meylan P., Manuel O., 2014. Transplantation, 97 (11) pp. 1192-1197.
[DOI][WoS][Pmid][serval:BIB_A203ABE021D0]
 
Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
Vermeiren P., Aubert V., Sugamele R., Aubert J.D., Venetz J.P., Meylan P., Pascual M., Manuel O., 2014. Transplant International, 27 (9) pp. 903-908.
[DOI][WoS][Pmid][serval:BIB_252EB74C8343]
 
Potential and limitations of regulatory T-cell therapy in solid organ transplantation.
Govender L., Pascual M., Golshayan D., 2014. Expert Review of Clinical Immunology, 10 (9) pp. 1197-1212.
[DOI][WoS][Pmid][serval:BIB_C2227C794334]
2013
 
Approche interdisciplinaire de la decision de don d'organes: l'experience lausannoise [An interdisciplinary approach of the organ donation decision: the Lausanne's experience].
Bosisio F., Merminod G., Burger M., Pascual M., Moretti D., Benaroyo L., 2013. Revue Médicale Suisse, 9 (408) pp. 2249-2253.
[Pmid][serval:BIB_590E607205BA]
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.
Koller M.T., van Delden C., Müller N.J., Baumann P., Lovis C., Marti H.P., Fehr T., Binet I., De Geest S., Bucher H.C. et al., 2013. European Journal of Epidemiology, 28 (4) pp. 347-355.
[URN][DOI][WoS][Pmid][serval:BIB_FD731E51329C]
 
European survey on the management of tuberculosis in solid-organ transplant recipients and candidates.
Boillat-Blanco N., Aguado J.M., Aubert J.D., Sester M., Grossi P., Kamar N., Pascual M., Manuel O., ESCMID Study Group of Infection in Compromised Hosts (ESGICH), 2013. Transplant International, 26 (8) pp. e69-e70. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_34D0411C1785]
 
Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs.
Perrottet N., Aubert V., Venetz J.P., Ugolini E., Matter M., Pannatier A., Pascual M., 2013. Transplantation, 95 (5) pp. e24-e25.
[DOI][WoS][Pmid][serval:BIB_DB6B15EEC4D0]
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
Manuel O., Kralidis G., Mueller N.J., Hirsch H.H., Garzoni C., van Delden C., Berger C., Boggian K., Cusini A., Koller M.T. et al., 2013. American Journal of Transplantation, 13 (9) pp. 2402-2410.
[URN][DOI][WoS][Pmid][serval:BIB_CEF33B24BED3]
 
Liver Transplantation for Neuroendocrine Tumors in Europe-Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study.
Le Treut Y.P., Grégoire E., Klempnauer J., Belghiti J., Jouve E., Lerut J., Castaing D., Soubrane O., Boillot O., Mantion G. et al., 2013. Annals of Surgery, 257 (5) pp. 807-815.
[DOI][WoS][Pmid][serval:BIB_3040AF5BD807]
 
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.
Schmidtko J., Peine S., El-Housseini Y., Pascual M., Meier P., 2013. American Journal of Kidney Diseases, 61 (2) pp. 289-299. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1C5156F18BCC]
2012
 
Relevance of cohort studies for the study of transplant infectious diseases.
Berger C., Boggian K., Cusini A., van Delden C., Garzoni C., Hirsch H.H., Khanna N., Koller M., Manuel O., Meylan P. et al., 2012/12. Current opinion in organ transplantation, 17 (6) pp. 581-585. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4671170BE51D]
 
MR imaging as a specific diagnostic tool for bilateral microcysts in chronic lithium nephropathy.
Golshayan D., Nseir G., Venetz J.P., Pascual M., Barbey F., 2012/03. Kidney International, 81 (6) p. 601. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4644BCFB9950]
Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease.
Friedrich L., Barbey F., Pascual M., Venetz J.P., 2012. Case Reports in Transplantation, 2012 p. 513025.
[URN][DOI][Pmid][serval:BIB_385EEC450CFB]
 
Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient.
Chehade H., Girardin E., Delich V., Pascual M.A., Venetz J.P., Cachat F., 2012. Transplant Infectious Disease, 14 (4) pp. E27-E29.
[DOI][WoS][Pmid][serval:BIB_F496174C3BA2]
 
Effects of immunosuppressive drugs on T helper cells subsets and potential to promote tolerance in a stringent experimental transplantation model.
Wyss J.C., Govender L., Pascual M., Golshayan D., 2012. pp. 462-463 dans American Transplant Congress 2012, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_2DC0F451FF00]
 
Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.
Manuel O., Baid-Agrawal S., Moradpour D., Pascual M., 2012. Contributions to Nephrology, 176 pp. 97-107.
[WoS][Pmid][serval:BIB_B335B0B01784]
 
Impact of Anti-T-Cell Therapy in the Immunogenicity of Seasonal Influenza Vaccine in Kidney Transplant Recipients.
Orcurto A., Pascual M., Hoschler K., Aubert V., Meylan P., Manuel O., 2012. Transplantation, 94 (6) pp. 630-636. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50AE47EF9B4C]
 
Rejets aigus
Venetz J.P., Pascual M., 2012. pp. 449-464 dans Legendre C. (eds.) Transplantation Rénale chap. 38, Médecine Sciences Publications.
[serval:BIB_10CE062CB880]
 
Strength and limitations of regulatory T Cells for immunotherapy in transplantation.
Govender L., Wyss J.C., Pascual M., Golshayan D., 2012. p. 448 dans American Transplant Congress 2012, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_313422EE568E]
2011
 
The definition of quality of life in solid organ transplantation: A psychological qualitative model
Piot-Ziegler C., Aubert J.D., Pascual M., 2011/09., the 15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics p. 246 dans Transplant international. Peer-reviewed.
[WoS][serval:BIB_DF05214DB0FB]
 
A model for organ donation in switzerland, the latin organ donation programme (lodp); an ongoing successful regional initiative
Moretti D., Heidegger C.P., Eckert P., Malacrida R., Pascual M., Revelly J.P., 2011. p. 153 dans 15th Congress of the European Society for Organ Transplantation and 22nd Annual Conference of the British Society for Histocompatibility and Immunogenetics, Transplant international. Peer-reviewed.
[WoS][serval:BIB_FCD929D3D732]
Diagnostic de la mort dans le contexte de la transplantation d'organes. Les directives.
Commission Centrale d'Ethique de l'ASSM, 2011. Bulletin des Médecins Suisses, 92 (32-33) pp. 1208-1210.
[URN][serval:BIB_18D45B94AC04]
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.A., Venetz J.P., Calandra T., Cavassini M., 2011. Clinical Infectious Diseases, 52 (2) pp. 248-256.
[URN][DOI][WoS][Pmid][serval:BIB_7D018B2FD982]
 
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N., Pascual M., Venetz J.P., Nseir G., Meylan P.R., Manuel O., 2011. Transplantation, 91 (2) pp. 251-255.
[DOI][WoS][Pmid][serval:BIB_4767174B2A23]
 
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
Lange C.M., Moradpour D., Doehring A., Lehr H.A., Müllhaupt B., Bibert S., Bochud P.Y., Antonino A.T., Pascual M., Farnik H. et al., 2011. Journal of Hepatology, 55 (2) pp. 322-327.
[DOI][WoS][Pmid][serval:BIB_DBA37AE7C4FE]
 
Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
Jankovic J., Pascual M., Venetz J.P., Nseir G., Meylan P., Manuel O., 2011. p. 323 dans ATC 2011, American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_F0F4917D7602]
 
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
Manuel O., Humar A., Berutto C., Ely L., Giulieri S., Lien D., Meylan P.R., Weinkauf J., Pascual M., Nador R. et al., 2011. Journal of Heart and Lung Transplantation, 30 (6) pp. 679-684.
[DOI][WoS][Pmid][serval:BIB_3C1DB6FEB256]
 
Monitoring of CD4(+)CD25(high)IL-7R alpha(high) activated T Cells in Kidney Transplant Recipients
Vallotton L., Hadaya K., Venetz J.P., Buehler L.H., Ciuffreda D., Nseir G., Codarri L., Villard J., Pantaleo G., Pascual M., 2011. Clinical Journal of the American Society of Nephrology, 6 (8) pp. 2025-2033.
[DOI][WoS][Pmid][serval:BIB_47D015ABFBCC]
 
Overlapping Pathways to Transplant Glomerulopathy: Chronic Humoral Rejection, Hepatitis C Infection and Thrombotic Microangiopathy
Baid-Agrawal S., Farris A.B., Pascual M., Mauiyyedi S., Farrell M.L., Tolkoff-Rubin N., Collins A.B., Colvin R.B., 2011. p. 401 dans ATC 2011, American Transplant Congress, American Journal of Transplantation.
[WoS][serval:BIB_EA0FCE644200]
 
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.
Baid-Agrawal S., Farris A.B., Pascual M., Mauiyyedi S., Farrell M.L., Tolkoff-Rubin N., Collins A.B., Frei U., Colvin R.B., 2011. Kidney International, 80 (8) pp. 879-885.
[DOI][WoS][Pmid][serval:BIB_D580FFAD406F]
 
Partager la vie : témoignages
Pascual M., 2011. pp. 160-173 dans Schneider P., Tissot J.D., Benzoni M., Ribes O. (eds.) Le sang : Arts, Sciences, Vie, Favre.
[serval:BIB_6C7DBA8191A7]
 
Prise en charge psychologique en transplantation d'organes : quel accompagnement pour les patients?
Piot-Ziegler C., Pascual M., 2011. Encyclopédie Médico-Chirurgicale, EMC pp. 1-44. Peer-reviewed.
[serval:BIB_09402668A7A6]
 
Programme latin de don d'organes (PLDO): une initiative efficace pour augmenter les dons d'organes en Suisse [Latin organ donation programme (LODP): an effective initiative to increase organ donation in Switzerland].
Heidegger C.P., Moretti D., Eckert P., Malacrida R., Pascual M., Revelly J.P., 2011. Revue Médicale Suisse, 7 (300) pp. 1368-1371.
[Pmid][serval:BIB_BCD9FC951222]
 
Renal transplantation following aorto-iliac reconstruction is a safe a strategy
Dubuis C., Deglise S., Saucy F., Saint-Lebes B., Venetz J.P., Pascual M., Corpataux J.M., 2011. p. 284 dans 15th Congress of the European Society for Organ Transplantation and 22nd Annual Conference of the British Society for Histocompatibility and Immunogenetics, Transplant international. Peer-reviewed.
[WoS][serval:BIB_01CD16BA19A8]
 
Sélection et suivi prétransplantation des patients candidats à la greffe cardiaque en Suisse romande [Selection and preoperative follow-up of heart transplantation candidates in the French part of Switzerland].
Yarol N., Tozzi P., von Segesser L., Kalangos A., Vogt P., Yerly P., Mach F., Pascual M., Meyer P., Hullin R., 2011. Revue Médicale Suisse, 7 (297) pp. 1212-1216.
[Pmid][serval:BIB_65831C6994A8]
 
Transplantation tolerance: Clinical potential of regulatory T cells.
Muller Y.D., Seebach J.D., Bühler L.H., Pascual M., Golshayan D., 2011. Self/nonself, 2 (1) pp. 26-34.
[DOI][Pmid][serval:BIB_FF871871F12F]
 
Treatment of Recurrent Hepatitis C after Liver Transplantation with PEG-Interferon and Ribavirin.
Antonino A.T., Fontana M., Gioastra E., Moradpour D., Pascual M., 2011. pp. S149 dans Joint International Congress of ILTS (International Liver Transplantation Society), ELITA (European Society for Organ Transplantation) and LICAGE (Liver Intensive Care Group of Europe), Liver Transplantation. Peer-reviewed.
[WoS][serval:BIB_AE556A5AE7DA]
 
Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland.
Jackson Y., Dang T., Schnetzler B., Pascual M., Meylan P., 2011. Journal of Heart and Lung Transplantation, 30 (4) pp. 484-485.
[DOI][WoS][Pmid][serval:BIB_3F056FABAD79]
 
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
Manuel O., Perrottet N., Pascual M., 2011. Expert Review of Anti-infective Therapy, 9 (11) pp. 955-965.
[DOI][WoS][Pmid][serval:BIB_A9C9384A62F6]
2010
 
Recommandations suisses pour la prise en charge des cancers cutanés chez les patients transplantés d'organe [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]
Lapointe A.K., Hofbauer G., Anliker M., Arnold A., Binet I., Hunger R., Kempf W., Pascual M., Pelloni F., Serra A. et al., 2010/04/28. Revue medicale suisse, 6 (246) pp. 854-859.
[Pmid][serval:BIB_FD91828E8754]
 
A Randomized Controlled Trial Comparing Intradermal vs. Intramuscular Influenza Vaccine in Lung Transplant Recipients
Manuel O, Humar A., Berutto C., Lien D., Giulieri S., Weinkauf J., Meylan P.R., Ely L., Pascual M., Nador R. et al., 2010. p. 208 dans 10th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_8A5E2030A4A8]
 
Absence of residual Hodgkin's disease demonstrated by PET/CT in a deceased organ donor.
Prior J.O., Duchosal M.A., Schmidt S., Turini P., Pilon N., Chioléro R., Pascual M., 2010/01. Transplant international, 23 (1) pp. 101-104. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C57AF25D17D]
 
Differential effects of immunosuppressive drugs on effector and regulatory T cells.
Wyss J.C., Mottet C., Lechler R., Pascual M., Golshayan D., 2010. pp. 7S-8S dans Annual Meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_E7BDD30EC5AA]
 
Ganciclovir exposure under a 450mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Meylan P.R., 2010. Clinical Transplantation, 24 (6) pp. 794-800.
[DOI][WoS][Pmid][serval:BIB_4C94E197C48C]
 
Giant warts in a kidney transplant patient: regression with sirolimus.
Kostaki M., Venetz J.P., Nseir G., Meylan P., Sahli R., Pascual M., Laffitte E., 2010. British Journal of Dermatology, 162 (5) pp. 1148-1150.
[DOI][WoS][Pmid][serval:BIB_00F7CD81351B]
 
Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
Ciuffreda D., Codarri L., Buhler L., Vallotton L., Giostra E., Mentha G., Morel P., Pantaleo G., Pascual M., 2010. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society, 16 (1) pp. 49-55.
[DOI][WoS][Pmid][serval:BIB_5D74E00D85A8]
 
Infection and chronic allograft dysfunction.
Dupont P.J., Manuel O., Pascual M., 2010. Kidney International. Supplement, 78 (119) pp. S47-S53.
[DOI][Pmid][serval:BIB_FB23C165F8B3]
 
Kidney transplant patients
Manuel Oriol, Baid-Agrawal Seema, Pascual Manuel, 2010. pp. 866-870 dans Cohen J., Opal S.M., Powderly W.G. (eds.) Infectious Diseases chap. 80, Mosby.
[serval:BIB_687A1677DB5B]
 
Natural killer cell receptor-repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.
Hadaya K., Avila Y., Valloton L., de Rham C., Bandelier C., Ferrari-Lacraz S., Pascual M., Pantaleo G., Martin P.Y., Buhler L. et al., 2010. Clinical Immunology, 137 (2) pp. 250-260.
[DOI][WoS][Pmid][serval:BIB_731757582EE2]
 
Prevalence of anti-HLA antibodies after liver transplantation.
Fontana M., Moradpour D., Aubert V., Pantaleo G., Pascual M., 2010. Transplant International, 23 (8) pp. 858-859.
[DOI][WoS][Pmid][serval:BIB_5D129DC921D7]
 
Recurrent Hepatitis C After Liver Transplantation Experience of the First 21 Patients Treated in Lausanne
Antonino Anca T., Fontana Massimiliano, Giostra Emiliano, Pascual Manuel, Moradpour Darius, 2010. pp. 20S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_6B134F00BF06]
 
Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient.
Mani L.Y., Nseir G., Venetz J.P., Pascual M., 2010. Transplantation, 90 (7) pp. 804-805.
[DOI][WoS][Pmid][serval:BIB_B87878B75E18]
 
Strategies for preventing late-onset cytomegalovirus disease in organ transplant recipients.
Manuel O, Pascual M., 2010. Trends in Transplantation, 4 (1) pp. 36-44.
[serval:BIB_C299F5DA473F]
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2010. pp. 35-39 dans Grinyo J.M., Vulto A.G. (eds.) Transplantation for European hospital pharmacists, Pharma Publishing and Media Europe.
[serval:BIB_9423089B3DB3]
Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.
Perrottet Nancy, Manuel Oriol, Lamoth Frederic, Venetz Jean-Pierre, Sahli Roland, Decosterd Laurent A., Buclin Thierry, Pascual Manuel, Meylan Pascal, 2010. BMC Infectious Diseases, 10 p. 2.
[URN][DOI][WoS][Pmid][serval:BIB_1123642915A2]
2009
Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
Hofbauer G.F., Anliker M., Arnold A., Binet I., Hunger R., Kempf W., Laffitte E., Lapointe A.C., Pascual M., Pelloni F. et al., 2009/07/25. Swiss medical weekly, 139 (29-30) pp. 407-415. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_00C4BE73949B]
 
Transplantation tolerance: from bench to bedside
Dela Golshayan, Manuel Pascual, 2009/04/01. Trends Transplant, 3 (1) pp. 3-12. Peer-reviewed.
[serval:BIB_9F20803AA70B]
 
Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant?
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Transplantation, 87 (12) pp. 1897-1898.
[DOI][WoS][Pmid][serval:BIB_B1BCD48E795C]
 
Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
Rosselet A., Vu D.H., Meylan P., Chaubert A.S., Schapira M., Pascual M., Aubert V., Tissot J.D., Duchosal M.A., 2009. Clinical Transplantation, 23 (1) pp. 74-82.
[DOI][WoS][Pmid][serval:BIB_A35C2CDCD130]
 
Dendritic Cell Modulation for Therapeutic Immunoregulation in Heart Transplantation
Roehrich M.E., Pascual M., Von Segesser L.K., Vogt P., Vassalli G., 2009. pp. 63-80 dans Fleming C.E. (eds.) Heart transplantation : indications and contraindications, procedures and complications, Nova Science.
[serval:BIB_B63ADFAD366C]
Die Schweizerische Transplantationskohortenstudie (STCS)
Kohler M., van Delden C., Pascual M., Müller N., Baumann P., Steiger J., 2009. Schweizerische Ärztezeitung, 90 (24) pp. 953-955.
[URN][serval:BIB_B0B2356436D1]
 
Donor's and organ representations in liver, kidney, heart and lung transplantation : a qualitative longitudinal study
Bosisio F., Bridy C., Pralong L., Szymanski J., Pascual M., Piot-Ziegler C., 2009. pp. 225-225 dans Abstracts of the 14th Congress of the European Society for Organ Transplantation, Transplant International. Peer-reviewed.
[WoS][serval:BIB_0B3330727A9F]
 
Donors/recipients representations about living-kidney donation : P-527
Pralong L., Pascual M., Santiago M., Venetz J.P., Piot-Ziegler C., 2009. p. 226 dans 14th Congress of the European Society for Organ Transplantation, Transplant International. Peer-reviewed.
[DOI][WoS][serval:BIB_434F1233204D]
 
Existential values transformation in all organ transplantation : a qualitative prospective study
Piot-Ziegler C., Ruffiner.Boner N. , Cuttelod T., Fonjallaz F., Pilon N., Pascual M., 2009. p. 317 dans From Knowledge to Interventions, 23rd Annual Conference of the European Health Psychology Society (EHPS), Psychology and Health. Peer-reviewed.
[serval:BIB_8983DA27727D]
 
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplant recipients: a prospective study : P125
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L., Buclin T., Meylan P., 2009. pp. 32S-33S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_80EADAB09A91]
 
Ganciclovir Exposure under a 450 mg Daily Dosage of Valganciclovir for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients.
Manuel Oriol, Pascual Manuel, Perrottet Nancy, Lamoth Frederic, Venetz Jean-Pierre, Decosterd Laurent, Buclin Thierry, Meylan Pascal R., 2009. p. 249 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_18DA47E61C5B]
 
High Specificity of C4d/CD68 Staining for the Diagnosis of Late Antibody-Mediated Rejection in Heart Transplantation.
Yerly Patrick, Rotmann Samuel, Hullin Roger, von Segesser Ludwig, Pascual Manuel, 2009. p. 656 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_6FB0640A2595]
 
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Human Immunology, 70 (8) pp. 580-583.
[DOI][WoS][Pmid][serval:BIB_C112FB3AA6A4]
Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability.
Golshayan D., Pascual M., Vogt B., 2009. Therapeutics and Clinical Risk Management, 5 (4) pp. 341-351. Peer-reviewed.
[URN][Pmid][serval:BIB_267B22276362]
No detectable indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frédéric, Manuel Oriol, Venetz Jean-Pierre, Faouzi Mohamed, Meylan Pascal, Pascual Manuel, 2009. pp. IMI-3, p. 62 dans Genes and Diseases, CHUV Research Day, January 29, 2009, Université de Lausanne, Faculté de biologie et de médecine.
[URN][serval:BIB_A95B244E2694]
 
Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD.
Meier P., Golshayan D., Blanc E., Pascual M., Burnier M., 2009. Journal of the American Society of Nephrology, 20 (6) pp. 1368-1384.
[DOI][WoS][Pmid][serval:BIB_70AF63850752]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University